is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines. It develops synthetic mRNA that instructs cells to produce proteins to prevent or treat diseases.

The importance of in vitro transcription as a component of the mRNA therapeutic manufacturing workflow has grown significantly in recent years. The in-process raw materials for synthetic mRNA ...

Eterna also makes synthetic mRNAs to express cell-reprogramming proteins and generate new cell types. “We can use our mRNA technology to re-write a cell’s gene-expression program, enabling a ...

The "Enzymatic DNA Synthesis Market by Service, by Application, by End-User, and By Region" report has been added to ...

Esphera SynBio, a pre-clinical stage synthetic biology company, has launched a new project aimed at enhancing the efficacy of ...

The company develops mRNA therapeutics and vaccines, and the move will enable it to utilise the synthetic biology and enzyme tech of 2018-founded Japanese company OriCiro, which develops cell-free ...

Researchers have successfully developed a modular synthetic translational coupling element (SynTCE), significantly enhancing the precision and integration density of genetic circuits in synthetic ...

On the synthetic side of this balance ... The amounts and types of mRNA molecules in a cell reflect the function of that cell. In fact, thousands of transcripts are produced every second in ...

CleanCap® enables a high-yield, streamlined manufacturing process that is cell-free and highly scalable for mRNA-based therapeutic and vaccine development. Unlike legacy methods, CleanCap offers a ...